YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition

Xiangyuan Luo(Tongji Hospital), Xingxing He(Nanchang University)
Experimental Hematology and Oncology
June 4, 2021
10.1186/s40164-021-00227-0
Cited by 101

Related Papers

Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
|Journal of Experimental & Clinical Cancer Research|2021|216
Autophagy inhibition enhanced 5‑FU‑induced cell death in human gastric carcinoma BGC‑823 cells
|Molecular Medicine Reports|2018|22
SRSF10 inhibition prevents HCC growth and metastasis and enhances the anti-PD-L1- mediated tumor suppression
|Research Square|2023|0